Get the Stockscreener App
23.28
1.02%
0.24
Overview
News
Price History
Option Chain
Financials
Why KVUE Down?
Discussions
Forecast
Dividend History
Kenvue Inc stock is traded at $23.28, with a volume of 5.44M.
It is up +1.02% in the last 24 hours and up +5.03% over the past month.
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
See More
Previous Close:
$23.04
Open:
$22.94
24h Volume:
5.44M
Relative Volume:
0.36
Market Cap:
$44.73B
Revenue:
$15.48B
Net Income/Loss:
$1.12B
P/E Ratio:
46.94
EPS:
0.496
Net Cash Flow:
$1.77B
1W Performance:
+2.17%
1M Performance:
+5.03%
6M Performance:
+21.22%
1Y Performance:
+20.16%
1-Day Range:
$22.92
$23.57
1-Week Range:
$22.56
$23.57
52-Week Range:
$17.67
$23.57
Kenvue Inc Stock (KVUE) Company Profile
Name
Kenvue Inc
Sector
Industry
Phone
908-874-1200
Address
199 GRANDVIEW ROAD, SKILLMAN
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-24-24 | Initiated | Jefferies | Buy |
| Sep-24-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-28-24 | Resumed | Citigroup | Neutral |
| Apr-11-24 | Initiated | Bernstein | Underperform |
| Apr-03-24 | Initiated | William Blair | Mkt Perform |
| Mar-01-24 | Resumed | Goldman | Neutral |
| Nov-17-23 | Initiated | Piper Sandler | Neutral |
| Sep-11-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-06-23 | Initiated | Argus | Hold |
| Aug-24-23 | Upgrade | Goldman | Neutral → Buy |
| Jul-25-23 | Initiated | Edward Jones | Buy |
| Jun-01-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Initiated | BofA Securities | Buy |
| May-30-23 | Initiated | Citigroup | Neutral |
| May-30-23 | Initiated | Deutsche Bank | Hold |
| May-30-23 | Initiated | Exane BNP Paribas | Neutral |
| May-30-23 | Initiated | Goldman | Neutral |
| May-30-23 | Initiated | JP Morgan | Overweight |
| May-30-23 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Initiated | UBS | Neutral |
View All
Kenvue Inc Stock (KVUE) Latest News
Kenvue stock hits 52-week high at $23.55 amid robust growth By Investing.com - Investing.com South Africa
Kenvue Canada expands manufacturing facility in Guelph, ON - Canadian Manufacturing
EXCLUSIVE: Andrew Stanleick Joins Kenvue - WWD
Kenvue Inc. (NYSE:KVUE) Receives Average Rating of "Hold" from Analysts - MarketBeat
Stay Ahead of the Game With Kenvue (KVUE) Q3 Earnings: Wall Street's Insights on Key Metrics - MSN
Kenvue Inc. (NYSE:KVUE) Shares Bought by US Bancorp DE - MarketBeat
Kenvue Canada Expands Ontario Manufacturing Facility to Boost Production of Over-the-Counter Medicines - Yahoo Finance
Northeast Investment Management Sells 36,041 Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat
Are Wall Street Analysts Bullish On Kenvue Stock? - Barchart
How Kenvue Avoided $3 Million In Wasted Media Spend - AdExchanger
International Assets Investment Management LLC Grows Holdings in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Neutrogena® Launches Breakthrough Collaboration with Two of World’s Most Recognizable Dermatologists - 뉴스와이어
Meet the 3.6%-Yielding Dividend King Stock That's Up 25% in 3 Months - AOL
Kenvue Inc. (NYSE:KVUE) Shares Purchased by abrdn plc - MarketBeat
This Big New Development Could Be Bullish for Kenvue Stock - MSN
Nisa Investment Advisors LLC Boosts Stock Holdings in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Kenvue (KVUE) Set to Announce Quarterly Earnings on Thursday - MarketBeat
Trajan Wealth LLC Buys 22,402 Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat
Kenvue: Unpacking Activist's Case And Earnings Preview (NYSE:KVUE) - Seeking Alpha
Caldwell Sutter Capital Inc. Has $546,000 Stock Holdings in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Forsta AP Fonden Purchases 34,400 Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat
Kenvue Inc. (NYSE:KVUE) Short Interest Down 31.1% in October - MarketBeat
3 Dividend Stocks to Double Up on Right Now - The Motley Fool
Pullen Investment Management LLC Takes $1.10 Million Position in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Trend Tracker for (KVUE) - Stock Traders Daily
How activist Starboard may help boost value in Kenvue's skin and beauty business - MSN
Top Stock Movers Now: Cigna, VF Corp., Kenvue, Boeing, and More - MSN
Osborne Partners Capital Management LLC Invests $1.04 Million in Kenvue Inc. (NYSE:KVUE) - MarketBeat
Kenvue stock gains 4% as FY earnings guidance tops estimates - MSN
Starboard takes stake in consumer products maker Kenvue, sources say - MSN
Is Kenvue Stock a Buy Now? - AOL
Jefferies reaffirms Buy on Kenvue stock, sees faster growth with Starboard’s push - Investing.com India
Starboard says Kenvue's skin health segment weighing on performance - MSN
DORCHESTER WEALTH MANAGEMENT Co Acquires 25,650 Shares of Kenvue Inc. (NYSE:KVUE) - MarketBeat
Starboard Makes Its Case to Shake-Up Pfizer and Kenvue - MSN
Stocks trading lower: Boeing, Kenvue, ASML, and more are big movers - MSN
Starboard says Kenvue's skin health segment is weighing on performance - MSN
Kenvue needs to fix its skin, health & beauty segments, Starboard's Jeff Smith says - MSN
Starboard Focused on Kenvue's Struggling Unit - The Wall Street Journal
What's Going On With Kenvue Stock Monday? - MSN
Starboard's Kenvue complaints are much different than those aimed at Pfizer - Endpoints News
Starboard Scolds Pfizer Over $20 Billion Value Destruction - Bloomberg
Kenvue needs to fix its skin, health & beauty segments, Starboard's Jeff Smith says (update) - Seeking Alpha
Kenvue (NYSE:KVUE) Price Target Raised to $27.00 - MarketBeat
Kenvue Inc Stock (KVUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.49%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):